Test Code LAB1277 JAK2 V617F Mutation Detection, Bone Marrow
Additional Codes
Mayo Test ID |
---|
JAK2M |
Performing Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Aiding in the distinction between a reactive blood cytosis and a chronic myeloproliferative disorder using bone marrow specimens
Testing Algorithm
For information see Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation.
Special Instructions
Method Name
Quantitative Polymerase Chain Reaction (PCR)
Reporting Name
JAK2 V617F Mutation Detection, BMSpecimen Type
Bone MarrowShipping Instructions
Specimen must arrive within 7 days of collection.
Specimen Required
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Yellow top (ACD)
Specimen Volume: 2 mL
Collection Instructions:
1. Invert several times to mix bone marrow.
2. Send bone marrow specimen in original tube. Do not aliquot.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Bone Marrow | Ambient (preferred) | 7 days | PURPLE OR PINK TOP/EDTA |
Refrigerated | 7 days | PURPLE OR PINK TOP/EDTA |
Reject Due To
Gross hemolysis | Reject |
Moderately to severely clotted | Reject |
Reference Values
An interpretive report will be provided.
Interpretation
The results will be reported as 1 of the 2 states:
-Negative for JAK2 V617F variant
-Positive for JAK2 V617F variant
Positive variant status is highly suggestive of a myeloid neoplasm but must be correlated with clinical and other laboratory features for definitive diagnosis.
Negative variant status does not exclude the presence of a myeloproliferative neoplasm or other neoplasm.
Results below the laboratory cutoff for positivity are of unclear clinical significance at this time.
Day(s) Performed
Monday through Friday
Report Available
2 to 5 daysSpecimen Retention Time
Bone marrow: 2 weeks; Extracted DNA: 3 monthsTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81270-JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
JAK2M | JAK2 V617F Mutation Detection, BM | 72333-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
39723 | JAK2 Result | 53761-3 |
31157 | JAK2 V617F Mutation Detection, BM | 72333-8 |
Forms
1. Hematopathology Patient Information (T676)
2. If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.